12/11
08:24 am
dyn
Rating for DYN
Low
Report
Rating for DYN
12/10
10:08 am
dyn
Rating for DYN
Low
Report
Rating for DYN
12/10
10:08 am
dyn
Rating for DYN
Low
Report
Rating for DYN
12/10
07:20 am
dyn
Dyne Therapeutics (NASDAQ:DYN) was upgraded by analysts at Oppenheimer Holdings, Inc. from a "market perform" rating to an "outperform" rating.
Low
Report
Dyne Therapeutics (NASDAQ:DYN) was upgraded by analysts at Oppenheimer Holdings, Inc. from a "market perform" rating to an "outperform" rating.
12/10
06:49 am
dyn
Dyne Therapeutics upgraded to Outperform from Perform at Oppenheimer
Low
Report
Dyne Therapeutics upgraded to Outperform from Perform at Oppenheimer
12/10
06:49 am
dyn
Dyne Therapeutics upgraded to Outperform from Perform at Oppenheimer
Low
Report
Dyne Therapeutics upgraded to Outperform from Perform at Oppenheimer
12/9
12:19 pm
dyn
Rating for DYN
Medium
Report
Rating for DYN
12/9
12:19 pm
dyn
Rating for DYN
Medium
Report
Rating for DYN
12/9
08:47 am
dyn
Dyne Therapeutics (NASDAQ:DYN) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $38.00 price target on the stock.
High
Report
Dyne Therapeutics (NASDAQ:DYN) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $38.00 price target on the stock.
12/9
08:20 am
dyn
Rating for DYN
High
Report
Rating for DYN
12/8
04:02 pm
dyn
Dyne Therapeutics (NASDAQ:DYN) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
High
Report
Dyne Therapeutics (NASDAQ:DYN) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
12/8
04:02 pm
dyn
Dyne Therapeutics (NASDAQ:DYN) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
High
Report
Dyne Therapeutics (NASDAQ:DYN) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
12/8
11:02 am
dyn
Dyne Therapeutics (NASDAQ:DYN) had its "strong-buy" rating reaffirmed by analysts at Raymond James Financial, Inc..
Medium
Report
Dyne Therapeutics (NASDAQ:DYN) had its "strong-buy" rating reaffirmed by analysts at Raymond James Financial, Inc..
11/25
07:19 am
dyn
Dyne Therapeutics (NASDAQ:DYN) had its "market perform" rating reaffirmed by analysts at Sanford C. Bernstein.
Low
Report
Dyne Therapeutics (NASDAQ:DYN) had its "market perform" rating reaffirmed by analysts at Sanford C. Bernstein.
11/14
10:50 am
dyn
Rating for DYN
Low
Report
Rating for DYN
11/12
11:14 am
dyn
Rating for DYN
Low
Report
Rating for DYN
11/12
11:14 am
dyn
Rating for DYN
Low
Report
Rating for DYN
11/6
02:04 pm
dyn
Dyne Therapeutics (NASDAQ:DYN) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Medium
Report
Dyne Therapeutics (NASDAQ:DYN) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
11/6
02:04 pm
dyn
Dyne Therapeutics (NASDAQ:DYN) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Medium
Report
Dyne Therapeutics (NASDAQ:DYN) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
11/6
11:12 am
dyn
Dyne Therapeutics (NASDAQ:DYN) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Dyne Therapeutics (NASDAQ:DYN) had its "buy" rating reaffirmed by analysts at HC Wainwright.
11/6
10:50 am
dyn
Rating for DYN
Medium
Report
Rating for DYN
11/6
10:50 am
dyn
Rating for DYN
Medium
Report
Rating for DYN
10/10
01:45 pm
dyn
Rating for DYN
Low
Report
Rating for DYN
10/10
01:45 pm
dyn
Rating for DYN
Low
Report
Rating for DYN
10/10
08:43 am
dyn
Dyne Therapeutics (NASDAQ:DYN) had its "market perform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
Low
Report
Dyne Therapeutics (NASDAQ:DYN) had its "market perform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..